(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Soft Tissue Sarcoma pipeline constitutes 70+ key companies continuously working towards developing 75+ Soft Tissue Sarcoma treatment therapies, analysis of
Soft Tissue Sarcoma Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, HER2 Negative Breast Cancer pipeline constitutes 70+ key companies continuously working towards developing 85+ HER2 Negative Breast Cancer treatment therapies,
HONG KONG – The 2025 International Automotive Supply Chain Expo (Hong Kong), co-hosted by the China Association of Automobile Manufacturers, Hong Kong Chinese Enterprises Association, The Chinese Manufacturers’ Association of
Cardiff, UK – June 13, 2025 – In a coaching world flooded with motivational fluff and recycled strategies, one voice is cutting through the noise with lived experience, cultural insight,
Kiwibit, a newcomer in the smart tech space, is excited to introduce Beako™, a new addition to its product portfolio
Jiaxing, China – June 13, 2025 – SalesPlastics.com, a China-based supplier of plastic and polymer resins, has officially launched its international
The Key Cutaneous T-cell Lymphoma Companies in the market include – Citius Pharmaceuticals, Soligenix, 4SC AG, Innate Pharma, Galderma R&D,
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Graft vs Host Disease pipeline constitutes 45+ key companies continuously
In response to the recent implementation of the “Liberation Day” tariffs by US President, Justicia Empresarial is proud to announce
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hypertriglyceridemia pipeline constitutes 18+ key companies continuously working towards developing
